Estimating the prevalence of poor-quality anti-TB medicines: a neglected risk for global TB control and resistance

OBJECTIVES: Tuberculosis (TB) remains a major global public health problem, especially with the recent emergence of multidrug-resistant TB and extensively drug-resistant TB. There has been little consideration of the extent of substandard and falsified (SF) TB medicines as drivers of resistance. We...

Descripción completa

Detalles Bibliográficos
Autores principales: Tabernero, Patricia, Newton, Paul N
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2023
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10347509/
https://www.ncbi.nlm.nih.gov/pubmed/37433693
http://dx.doi.org/10.1136/bmjgh-2023-012039

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10347509/
https://www.ncbi.nlm.nih.gov/pubmed/37433693
http://dx.doi.org/10.1136/bmjgh-2023-012039

Ejemplares similares